Ilana F. Gareen

Also affiliated with ECOG-ACRIN Cancer Research Group

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 35 papers. Top paper: “Cost-Effectiveness of CT Screening in the National Lung Screening Trial”.

Cost-Effectiveness of CT Screening in the National Lung Screening Trial

New England Journal of Medicine(2014)10.1056/nejmoa1312547

N/A

17.9DataRank · unranked

554 citations

Ilana F. Gareen, Samir S. Soneji, JoRean D. Sicks, Emmett B. Keeler, Denise R. Aberle +6 more

Importance of Low- and Moderate-Grade Adverse Events in Patients' Treatment Experience and Treatment Discontinuation: An Analysis of the E1912 Trial

Journal of Clinical Oncology(2023)10.1200/jco.23.00377

N/A

2.3DataRank · unranked

46 citations

Fengmin Zhao, Ju‐Whei Lee, Edward H. Ip, John Devin Peipert, Noah Graham +11 more

A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG‐ACRIN Cancer Research Group (EAQ152)

Cancer(2021)10.1002/cncr.34063

N/A

0.616DataRank · unranked

15 citations

Ju‐Whei Lee, Jill B. Gaieski, Shuli Li, Ilana F. Gareen, Keith T. Flaherty +15 more

Early Increases in Blood Pressure and Major Adverse Cardiovascular Events in Patients With Renal Cell Carcinoma and Thyroid Cancer Treated With VEGFR TKIs

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2023.7047

N/A

0.421DataRank · unranked

11 citations

Tao Liu, Xue Song, Joshua D. Mitchell, JoRean D. Sicks, Ilana F. Gareen +10 more

Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2–negative breast cancer: A trajectory analysis of adverse events

Cancer(2021)10.1002/cncr.33992

N/A

0.266DataRank · unranked

4 citations

Santiago Saldana, Kathy D. Miller, Ruth C. Carlos, Ilana F. Gareen, Joseph A. Sparano +9 more

Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices [Smokefree Support Study 2.0]

BMC Public Health(2022)10.1186/s12889-022-13631-w

N/A

0.229DataRank · unranked

3 citations

Autumn W. Rasmussen, Lynne I. Wagner, JoRean D. Sicks, Ilana F. Gareen, Ruth C. Carlos +17 more

Neighborhood socioeconomic disadvantage, tobacco use, and cessation indicators among adults with cancer in the United States: Results from 10 ECOG-ACRIN trials.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6514

N/A

0.189DataRank · unranked

2 citations

Ju‐Whei Lee, Ilana F. Gareen, Sheetal Kircher, B. Herman, Joanna M. Streck +14 more

Adjusting the TMIST study design to accommodate slower than expected accrual: ECOG-ACRIN EA1151.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps10614

N/A

0.104DataRank · unranked

1 citations

Constantine Gatsonis, Mitchell D. Schnall, Martin J. Yaffe, Melissa A. Troester, Ilana F. Gareen +9 more

Improving CDK4/6 inhibitors adherence in breast cancer using the CONnected CUstomized Treatment Platform (CONCURxP) mobile health intervention: Study protocol for ECOG-ACRIN EAQ221CD

Contemporary Clinical Trials(2025)10.1016/j.cct.2025.108145

N/A

0.104DataRank · unranked

1 citations

Fenghai Duan, Ilana F. Gareen, Judy Hancock, JoRean D. Sicks, Maryanne Thangarajah +8 more

Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)

Radiology(2021)10.1148/radiol.2021219016

N/A

0DataRank · unranked

5 citations

Justin Romanoff, Constance D. Lehman, Seema A. Khan, Ruth C. Carlos, Sunil Badve +17 more

Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)

Radiology(2021)10.1148/radiol.2021204743

N/A

0DataRank · unranked

38 citations

Justin Romanoff, Constance D. Lehman, Seema A. Khan, Ruth C. Carlos, Sunil Badve +17 more

Engaging the radiology community in the National Clinical Trials Network: The ECOG-ACRIN TMIST experience.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps10609

N/A

0DataRank · unranked

0 citations

Constantine Gatsonis, Mitchell D. Schnall, Martin D. Yaffe, Melissa A. Troester, Ilana F. Gareen +8 more

Association between allostatic load, symptom burden and mortality in E1A11 trial for myeloma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.12102

N/A

0DataRank · unranked

0 citations

Noah Graham, Shaji Kumar, Ju‐Whei Lee, David Cella, Fengmin Zhao +9 more

Baseline and short-term financial burden (FB) in colorectal cancer (CRC) treated with curative intent: Early results of ECOG-ACRIN EAQ162CD.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.1518

N/A

0DataRank · unranked

0 citations

Fenghai Duan, Ilana F. Gareen, Ellen Underwood, JoRean D. Sicks, Jennifer M. Suga +7 more

Predictors of surgery preference and quality of life in DCIS after breast MRI: A trial of the ECOG-ACRIN Cancer Research Group (E4112).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6564

N/A

0DataRank · unranked

0 citations

Bradley S. Snyder, Ilana F. Gareen, Constance D. Lehman, Seema A. Khan, Justin Romanoff +14 more

Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patients

Blood Cancer Journal(2022)10.1038/s41408-022-00648-y

N/A

0DataRank · unranked

25 citations

Noah Graham, Shaji Kumar, Ju‐Whei Lee, Susanna Jacobus, Matthias Weiss +12 more

Randomized trial of web-based genetic education versus usual care in advanced cancer patients undergoing tumor genetic testing: Results from the ECOG-ACRIN NCI Community Oncology Research Program (NCORP; EAQ152) COMET trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2008

N/A

0DataRank · unranked

0 citations

Ju‐Whei Lee, Jill B. Gaieski, Shuli Li, Ilana F. Gareen, Keith T. Flaherty +15 more

Increase in side effect bother was associated with early treatment discontinuation in a clinical trial among multiple myeloma patients.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e19136

N/A

0DataRank · unranked

5 citations

Fengmin Zhao, Ju‐Whei Lee, Fangxin Hong, Edward H. Ip, Ilana F. Gareen +9 more

Longitudinal changes in financial burden in patients with colorectal cancer treated with curative intent: Primary results of EAQ162CD.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6597

N/A

0DataRank · unranked

1 citations

Fenghai Duan, Ellen Underwood, Ilana F. Gareen, JoRean D. Sicks, Gelareh Sadigh +11 more

Predictive value of baseline patient-rated treatment bother for early anastrozole discontinuation in a racially diverse cohort: Results from ECOG-ACRIN E1Z11.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12094

N/A

0DataRank · unranked

0 citations

John Devin Peipert, Vered Stearns, Victor T. Chang, Opeyemi A. Jegede, Edward H. Ip +15 more

ECOG-ACRIN tomosynthesis mammographic imaging screening trial (EA1151).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps1597

N/A

0DataRank · unranked

1 citations

Constantine Gatsonis, Martin J. Yaffe, Melissa A. Troester, Ilana F. Gareen, Laura C. Collins +6 more

Early discontinuation to adjuvant endocrine therapy in the ECOG-ACRIN TAILORx Trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.7004

N/A

0DataRank · unranked

1 citations

Robert J. Gray, Joseph A. Sparano, Ruth C. Carlos, Gelareh Sadigh, Sofia F. Garcia +6 more

Cigarette and Alternative Tobacco Product Use among Adult Cancer Survivors Enrolled in 9 ECOG-ACRIN Clinical Trials

Cancer Epidemiology Biomarkers & Prevention(2023)10.1158/1055-9965.epi-23-0420

N/A

0DataRank · unranked

7 citations

Ju‐Whei Lee, Angela Wangari Walter, Rachel Rosen, Ilana F. Gareen, Sheetal Mehta Kircher +17 more

Utilization of Diagnostic Procedures After Lung Cancer Screening in the National Lung Screening Trial

Journal of the American College of Radiology(2023)10.1016/j.jacr.2023.03.021

N/A

0DataRank · unranked

2 citations

Tao Liu, Constantine Gatsonis, JoRean D. Sicks, Stephannie Shih, Ruth C. Carlos +2 more

Incidence round screening performance among women with dense breasts undergoing abbreviated breast MRI and digital breast tomosynthesis (ECOG-ACRIN EA1141).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10502

N/A

0DataRank · unranked

7 citations

Constantine Gatsonis, Gillian M. Newstead, Bradley S. Snyder, Na An, Ilana F. Gareen +13 more

Smoking cessation support and knowledge among newly diagnosed individuals at community cancer centers (ECOG-ACRIN trial EAQ171CD).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1522

N/A

0DataRank · unranked

0 citations

Jamie S. Ostroff, JoRean D. Sicks, Brett M. Goshe, Ilana F. Gareen, B. Herman +14 more

Patient-Reported Adverse Events and Early Treatment Discontinuation Among Patients With Multiple Myeloma

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.3854

N/A

0DataRank · unranked

21 citations

Fengmin Zhao, Ju‐Whei Lee, Shu-en Shen, Edward H. Ip, Nathaniel S. O’Connell +12 more

Cigarette Smoking and Symptom Burden: Baseline Results From Nine ECOG-ACRIN Cancer Clinical Trials

Journal of Pain and Symptom Management(2024)10.1016/j.jpainsymman.2024.12.021

N/A

0DataRank · unranked

2 citations

Ju‐Whei Lee, Ilana F. Gareen, Sheetal Mehta Kircher, Shaji Kumar, Ingrid A. Mayer +10 more

Exploring Gender Differences in Receipt of the 5As for Smoking Cessation for Recently Diagnosed Cancer Patients (ECOG-ACRIN EAQ171CD)

Nicotine & Tobacco Research(2024)10.1093/ntr/ntae304

N/A

0DataRank · unranked

2 citations

Jo Rean D Sicks, Lynne I. Wagner, Ruth C. Carlos, Isabelle Miranda, Rachel L Rosen +17 more

Overall side‐effect bother consistently associated with early treatment discontinuation due to adverse events in four clinical trials with various cancer types and treatments

Cancer(2025)10.1002/cncr.70084

N/A

0DataRank · unranked

2 citations

Shaili Ganatra, Fengmin Zhao, Ju‐Whei Lee, Jessica Roydhouse, Edward H. Ip +13 more

Effectiveness of out-of-pocket cost COMmunication and financial navigation (CostCOM) in cancer patients: Study protocol for ECOG-ACRIN EAQ222CD

Contemporary Clinical Trials(2025)10.1016/j.cct.2025.107889

N/A

0DataRank · unranked

0 citations

Fenghai Duan, Ilana F. Gareen, Judy Hancock, JoRean D. Sicks, Sarah T. Hawley +5 more

The effect of neighborhood socioeconomic disadvantage on smoking status, quit attempts, and receipt of cessation support among adults with cancer: Results from nine ECOG‐ACRIN Cancer Research Group trials

UNC Libraries(2025)10.17615/c1xc-d466

N/A

0DataRank · unranked

0 citations

Ju‐Whei Lee, Sheetal Mehta Kircher, Lynne I. Wagner, Frank S. Hodi, Jamie S. Ostroff +16 more

Patient-Reported Testing Burden of Breast Magnetic Resonance Imaging Among Women With Ductal Carcinoma In Situ

JAMA Network Open(2021)10.1001/jamanetworkopen.2021.29697

N/A

0DataRank · unranked

15 citations

Bradley S. Snyder, Ilana F. Gareen, Constance D. Lehman, Seema A. Khan, Justin Romanoff +7 more

Predictive value of bother by side effects of treatment prior to protocol therapy for early treatment discontinuation in clinical trials.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e19132

N/A

0DataRank · unranked

3 citations

John Devin Peipert, Ju‐Whei Lee, Fangxin Hong, Edward H. Ip, Ilana F. Gareen +15 more

Fatigue and endocrine symptoms among women with early breast cancer randomized to endocrine versus chemoendocrine therapy: Results from the TAILORx patient‐reported outcomes substudy

Cancer(2021)10.1002/cncr.33939

N/A

0DataRank · unranked

5 citations

Robert J. Gray, Joseph A. Sparano, Amyé Tevaarwerk, Ruth C. Carlos, Betina R. Yanez +6 more